Decision of the EEA Joint Committee No 144/2018 of 6 July 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2021/206]
Date: 2018-07-06
Institutions: EEA Joint Committee
Subjects: European Economic Area, market approval, plant health control, plant health product, revision of an agreement




L_2021067EN.01003501.xml










25.2.2021   


EN


Official Journal of the European Union


L 67/35








            DECISION OF THE EEA JOINT COMMITTEE
         
No 144/2018
of 6 July 2018
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2021/206]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2018/84 of 19 January 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, clothianidin, copper compounds, dimoxystrobin, mancozeb, mecoprop-p, metiram, oxamyl, pethoxamid, propiconazole, propineb, propyzamide, pyraclostrobin and zoxamide (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2018/112 of 24 January 2018 renewing the approval of the low-risk active substance laminarin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2018/113 of 24 January 2018 renewing the approval of the active substance acetamiprid in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2018/155 of 31 January 2018 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Regulation (EU) 2018/184 of 7 February 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances FEN 560 (also called fenugreek or fenugreek seed powder) and sulfuryl fluoride (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Regulation (EU) 2018/185 of 7 February 2018 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance penflufen (6) is to be incorporated into the EEA Agreement.












(7)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






(1)


the following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32018 R 0084: Commission Implementing Regulation (EU) 2018/84 of 19 January 2018 (OJ L 16, 20.1.2018, p. 8),










—



32018 R 0112: Commission Implementing Regulation (EU) 2018/112 of 24 January 2018 (OJ L 20, 25.1.2018, p. 3),










—



32018 R 0113: Commission Implementing Regulation (EU) 2018/113 of 24 January 2018 (OJ L 20, 25.1.2018, p. 7),










—



32018 R 0184: Commission Implementing Regulation (EU) 2018/184 of 7 February 2018 (OJ L 34, 8.2.2018, p. 10),










—



32018 R 0185: Commission Implementing Regulation (EU) 2018/185 of 7 February 2018 (OJ L 34, 8.2.2018, p. 13).’;














(2)


the following indent is added in point 13zzze (Commission Implementing Regulation (EU) No 686/2012):






‘—



32018 R 0155: Commission Implementing Regulation (EU) 2018/155 of 31 January 2018 (OJ L 29, 1.2.2018, p. 8).’;














(3)


the following points are inserted after point 13zzzzzzzzl (Commission Implementing Regulation (EU) 2017/2324):






‘13zzzzzzzzm.



32018 R 0112: Commission Implementing Regulation (EU) 2018/112 of 24 January 2018 renewing the approval of the low-risk active substance laminarin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 20, 25.1.2018, p. 3).










13zzzzzzzzn.



32018 R 0113: Commission Implementing Regulation (EU) 2018/113 of 24 January 2018 renewing the approval of the active substance acetamiprid in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 20, 25.1.2018, p. 7).’










Article 2
The texts of Implementing Regulations (EU) 2018/84, (EU) 2018/112, (EU) 2018/113, (EU) 2018/155, (EU) 2018/184 and (EU) 2018/185 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 7 July 2018, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 6 July 2018.


For the EEA Joint Committee


The President

Oda Helen SLETNES
            





(1)  
            OJ L 16, 20.1.2018, p. 8.

(2)  
            OJ L 20, 25.1.2018, p. 3.

(3)  
            OJ L 20, 25.1.2018, p. 7.

(4)  
            OJ L 29, 1.2.2018, p. 8.

(5)  
            OJ L 34, 8.2.2018, p. 10.

(6)  
            OJ L 34, 8.2.2018, p. 13.

(*1)  No constitutional requirements indicated.